Inosan Biopharma Logo

Inosan Biopharma

At Inosan Biopharma we develop and distribute the latest generation antivenoms that meet highest manufacturing standars. Inosan is a biotechnology company that has integrated innovation and internal development of knowledge and technology to manufacture medicines for vulnerable patients' emergencies. Not all products and/or indications are available in all territories. Is a polyvalent equine antivenom specifically indicated for the treatment of Sub- Middle East and North African snake bites. Is a polyvalent equine antivenom specifically indicated for the treatment of Sub-Saharan African snake bites. Is a polyvalent equine antivenom specifically indicated for the treatment of Middle East and North African scorpion stings. It is a biological therapy indicated for the treatment of poisoning by bites or stings of venomous or poisonous animals; for example, snakes, scorpions and spiders whose function is to counteract the effects of a venom or at least prevent the undesirable damage of the toxic compounds. Serum, purified biological product of moderate efficacy and safety.

Quick overview

Mexico City, Mexico

Founded in 2012

51-100 Employees

Medium-Sized

Additional information

Working industry

Pharmaceuticals

Type of company

Manufacturer

Ownership structure

Privately Held

Locations

2 Locations

Number of products

1 Product

Specialised areas

Pharmaceuticals, Immonuglobulins, Antivenoms

Products & services of Inosan Biopharma

Inosan Biopharma offers a wide range of products and services

Product: PRODUCTS

Product

PRODUCTS

Go to product >

Headquarter of Inosan Biopharma

Inosan Biopharma operates in 2 countries around the world

City: Mexico City

State: Mexico City

Country: Mexico

Locations of Inosan Biopharma

Get an overview of the locations of Inosan Biopharma

Location

Country

State

City

Headquarter

Mexico

Mexico City

Mexico City

Arbea Campus Empresarial

Spain

Community of Madrid

Alcobendas

Frequently asked questions (FAQ) about Inosan Biopharma

Some frequent questions that have been asked about Inosan Biopharma

The company headquarter of Inosan Biopharma is located in Mexico City, Mexico City, Mexico. Inosan Biopharma has subsidiaries in Spain

As of the latest available information Inosan Biopharma has around 51-100 employees worldwide.

Inosan Biopharma was founded in 2012

The company Inosan Biopharma has it's main focus in the industries of Pharmaceuticals

Based on the founding year and the amount of employees the company Inosan Biopharma seems to be a Medium-Sized at the current state. Note that over time that status can change

Competitors of Inosan Biopharma

Check out some interesting alternative companies to Inosan Biopharma

ToxiVen's Logo

ToxiVen

Coimbatore, India

11-50 Employees

2019

Since ToxiVen realises the therapeutic and scientific value of a broad spectrum of toxins present in vertebrate & invertebrate venoms and poisons, in partnership with Venomtech Limited (UK), we offer arrays (from over 200 species of snakes, spiders, scorpions, millipedes and lizards) of venoms and poisons, and their fractions for novel drug discovery which has an established success rate of over 98% to leading academic institutions and pharmaceutical industries. In ToxiVen’s point of view, venoms are a ‘Bio-Treasure’. Therefore, we provide a range of venoms, venom products and venom antibodies for basic scientific and clinical research. We are committed to bring world class whole venoms, venom components, venom antibodies, venom arrays and general antibodies in to the market for the effective treatment of snakebite, and also drug discovery. Together with a team of world-leading experts, ToxiVen tackles the complications of snakebite envenoming via developing diagnostic tools and next generation therapeutics.

Elusys Therapeutics, Inc.'s Logo

Elusys Therapeutics, Inc.

Parsippany-Troy Hills, United States

11-50 Employees

1998

Elusys Therapeutics leverages immune-stimulatory and immune-derived therapies to combat infectious disease. Our mission is to accelerate the development and commercialization of novel biodefense solutions to defend tomorrow today. Elusys Therapeutics is dedicated to delivering innovative medical countermeasures that enable fast, effective, and durable protection against infectious agents. Our goal is to accelerate the development and commercialization of novel biodefense solutions, such as our anthrax antitoxin ANTHIM® (obiltoxaximab), for strategic government partners. Elusys was also contracted as of 2022 to deliver ANTHIM to the Public Health Agency of Canada. Anthrax is a disease caused by Bacillus anthracis and is regarded as a top (“Category A”) biological warfare and bioterrorism threat. Obiltoxaximab is a monoclonal anthrax antitoxin licensed as ANTHIM® in the United States and Canada and as NYXTHRACIS® in Great Britain and the European Union. ANTHIM® has been delivered to the US Strategic National Stockpile as the result of a successful multi-year partnership with the US government.

Latoxan's Logo

Latoxan

Portes-lès-Valence, France

1-10 Employees

1982

LATOXAN is the leading producer of venoms from snakes, scorpions and batrachians with over 300 different venoms worldwide available. LATOXAN also produces and supplies venom toxins, plant, plant small molecules and screening libraries. LATOXAN supplies Pharmaceutical Industry, Academic and Pharma Research centres and worldwide distributors of Life Science Reagents. Based on a long-standing experience in zoology, LATOXAN is a fully independent company dedicated to the production and sales of high quality venoms and toxins.Founded in 1982, LATOXAN is now a leading supplier in this field, selling to pharmaceutical companies, medical research laboratories and drug discovery units throughout the world.Venoms are produced under strictly controlled conditions from animals we have collected in all parts of the world, or which were born and reared in our breeding facilities.Purified toxins, plant compounds and other similar pharmacological tools are produced in cooperation with leading research institutions. Most molecules provided come with a purity ⪚98%.

Inovio Pharmaceuticals's Logo

Inovio Pharmaceuticals

Whitemarsh Township, United States

251-500 Employees

1979

INOVIO is a clinical-stage biotechnology company focused on developing DNA medicines to fight HPV-related diseases, cancer and infectious diseases. We are building a uniquely experienced team, with a focus on scientific and operational excellence, to bring our DNA medicine candidates to market to benefit patients." Learn More. We are dedicated to delivering on that promise.” Learn More. Our proprietary investigational CELLECTRA® delivery devices help ensure our DNA medicines enter the body’s cells for optimal effect, without chemical adjuvants or nanoparticles and without the risk of the anti-vector response seen in viral vector platforms. DNA medicine offers ground-breaking potential advantages.” Learn More.

InBios's Logo

InBios

Seattle, United States

51-100 Employees

1996

InBios is a leading biotechnology company based in Seattle, Washington (USA). At InBios, we believe an accurate diagnosis is the first step to effective treatment. InBios has a long history of market leadership. InBios also specializes in the development and manufacture of highly specific and well-characterized antibodies and antigens for use in infectious disease research. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified. InBios is a total solution company with expertise in all facets of the product pipeline, from discovery to application. From concept to clinic, InBios partners with private companies, federal laboratories and academia to bring our customers the best scientific solutions for their diagnostic needs. InBios Awarded New Contract to Supply COVID-19 Tests as Part of HHS/ASPR Effort to Strengthen Domestic Supply Chain.

inuvet's Logo

inuvet

Lörrach, Germany

1-10 Employees

-

And best of all, Inuvet products are all based on herbal ingredients, making them very well-tolerated by animals. Inuvet product sales are handled exclusively by your practice. Together, we develop phytotherapeutics exclusively for veterinary practices, taking into account the latest scientific findings. With the new Inuvet packaging, you as a veterinarian have an ecological alternative for your patient owners. You are the expert in animal health, and we offer you the best natural products for your daily practice. Whether you’re after products for dogs, cats, horses, chickens or hamsters, you will find the right product with us for all of your cases. You can find everything on the Internet – except Inuvet products. In this way, we can work together to provide your patients with the best possible care.

Suitable topics for Inosan Biopharma

Topics which have been searched by others and may be interesting for you: